‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
Beyond the arrhythmia, AF often signals broader pathological processes that impair cardiac function and reduce quality of life and life expectancy.5 Many of these conditions are closely linked to social determinants of health, disproportionately affecting populations with socioeconomic disadvantage. Effective AF management requires addressing both the arrhythmia and its underlying contributors.4 
C – Comorbidity and risk factor management
WarfarinCurrent evidence for medicinal cannabis
Cannabis is the most popular recreational drug used in the world. The use of cannabis or cannabinoids is referred to as medicinal cannabis.
Learning objectives...
Choosing wisely to achieve medicine safety
The quality use of medicines is vital to ensure a sustainable healthcare system and better health outcomes for consumers.
This was the dominant theme at...
Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
Offshore refresher: live and learn
PSA’s Offshore Refresher Conference this year took members to Europe. ECP Sinead Stone MPS went along, courtesy of a grant from Bayer.
It was...
Royal Pharmaceutical Society director on the future of pharmacy
Ravi Sharma’s credentials in pharmacy are formidable. Recently appointed the Royal Pharmaceutical Society’s (RPS’s) director for England, he was also National Clinical Lead for...
Ensuring patients’ medical data is secure
The rollout of My Health Record has raised questions surrounding the security of medical data. What measures must be taken in pharmacies to preserve...
